1. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation
   Lucile Dumolard et al, 2023, Frontiers in Immunology CrossRef
2. Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic disease
   Ming-Han Chen et al, 2021, Annals of the Rheumatic Diseases CrossRef
3. Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen
   Sheila F. Lumley et al, 2018, Frontiers in Immunology CrossRef
4. Immunotherapy for Chronic Hepatitis B Virus Infection
   涛 巫, 2019, Pharmacy Information CrossRef
5. PD-1-Mediated PI3K/Akt/mTOR, Caspase 9/Caspase 3 and ERK Pathways Are Involved in Regulating the Apoptosis and Proliferation of CD4+ and CD8+ T Cells During BVDV Infection in vitro
   Yu Liu et al, 2020, Frontiers in Immunology CrossRef
6. Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
   Xin Cai et al, 2021, Frontiers in Genetics CrossRef
7. Hepatitis B functional cure and immune response
   Jia-Rui Zheng et al, 2022, Frontiers in Immunology CrossRef
8. Modulation of cellular autophagy by genotype 1 hepatitis E virus ORF3 protein
   Manjita Srivastava et al, 2023, Journal of General Virology CrossRef
9. Research Progress on the Mechanism of Persistent Low-Level HBsAg Expression in the Serum of Patients with Chronic HBV Infection
   Jie Wu et al, 2022, Journal of Immunology Research CrossRef
10. The kinetics of inhibitory immune checkpoints during and post-COVID-19: the knowns and unknowns
    Ensiye Torki et al, 2023, Clinical and Experimental Medicine CrossRef